KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to $50.7 billion.

  • Eli Lilly's Total Non-Current Liabilities rose 4060.78% to $50.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $50.7 billion, marking a year-over-year increase of 4060.78%. This contributed to the annual value of $50.7 billion for FY2025, which is 4060.78% up from last year.
  • Latest data reveals that Eli Lilly reported Total Non-Current Liabilities of $50.7 billion as of Q4 2025, which was up 4060.78% from $50.9 billion recorded in Q3 2025.
  • In the past 5 years, Eli Lilly's Total Non-Current Liabilities registered a high of $50.9 billion during Q3 2025, and its lowest value of $21.6 billion during Q4 2022.
  • Moreover, its 5-year median value for Total Non-Current Liabilities was $26.3 billion (2021), whereas its average is $31.1 billion.
  • Per our database at Business Quant, Eli Lilly's Total Non-Current Liabilities crashed by 1848.56% in 2022 and then surged by 4876.98% in 2024.
  • Eli Lilly's Total Non-Current Liabilities (Quarter) stood at $24.6 billion in 2021, then decreased by 12.29% to $21.6 billion in 2022, then increased by 19.81% to $25.8 billion in 2023, then surged by 39.53% to $36.1 billion in 2024, then soared by 40.61% to $50.7 billion in 2025.
  • Its last three reported values are $50.7 billion in Q4 2025, $50.9 billion for Q3 2025, and $43.6 billion during Q2 2025.